vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and MOVADO GROUP INC (MOV). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $186.1M, roughly 1.1× MOVADO GROUP INC). MOVADO GROUP INC runs the higher net margin — 5.1% vs -14.6%, a 19.7% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 1.9%). MOVADO GROUP INC produced more free cash flow last quarter ($11.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 2.9%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Movado is a luxury American watch brand originally founded in 1881 in Switzerland. Movado means "movement" in Esperanto. The watches are known for their signature metallic dot at 12 o'clock and minimalist style; the company is best known for its Museum Watch.
AXSM vs MOV — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $186.1M |
| Net Profit | $-28.6M | $9.6M |
| Gross Margin | — | 54.3% |
| Operating Margin | -13.8% | 6.3% |
| Net Margin | -14.6% | 5.1% |
| Revenue YoY | 65.0% | 1.9% |
| Net Profit YoY | 61.9% | 89.8% |
| EPS (diluted) | $-0.55 | $0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $186.1M | ||
| Q3 25 | $171.0M | $161.8M | ||
| Q2 25 | $150.0M | $131.8M | ||
| Q1 25 | $121.5M | $181.5M | ||
| Q4 24 | $118.8M | $180.5M | ||
| Q3 24 | $104.8M | $157.0M | ||
| Q2 24 | $87.2M | $134.4M | ||
| Q1 24 | $75.0M | $175.8M |
| Q4 25 | $-28.6M | $9.6M | ||
| Q3 25 | $-47.2M | $3.0M | ||
| Q2 25 | $-48.0M | $1.4M | ||
| Q1 25 | $-59.4M | $8.1M | ||
| Q4 24 | $-74.9M | $4.8M | ||
| Q3 24 | $-64.6M | $3.5M | ||
| Q2 24 | $-79.3M | $2.0M | ||
| Q1 24 | $-68.4M | $9.8M |
| Q4 25 | — | 54.3% | ||
| Q3 25 | — | 54.1% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 54.2% | ||
| Q4 24 | — | 53.5% | ||
| Q3 24 | — | 54.3% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | 53.5% |
| Q4 25 | -13.8% | 6.3% | ||
| Q3 25 | -27.0% | 2.5% | ||
| Q2 25 | -24.5% | 0.2% | ||
| Q1 25 | -46.9% | 5.1% | ||
| Q4 24 | -61.1% | 3.3% | ||
| Q3 24 | -59.8% | 1.7% | ||
| Q2 24 | -89.5% | 1.6% | ||
| Q1 24 | -89.7% | 6.1% |
| Q4 25 | -14.6% | 5.1% | ||
| Q3 25 | -27.6% | 1.8% | ||
| Q2 25 | -32.0% | 1.1% | ||
| Q1 25 | -48.9% | 4.4% | ||
| Q4 24 | -63.1% | 2.7% | ||
| Q3 24 | -61.7% | 2.2% | ||
| Q2 24 | -91.0% | 1.5% | ||
| Q1 24 | -91.1% | 5.6% |
| Q4 25 | $-0.55 | $0.42 | ||
| Q3 25 | $-0.94 | $0.13 | ||
| Q2 25 | $-0.97 | $0.06 | ||
| Q1 25 | $-1.22 | $0.36 | ||
| Q4 24 | $-1.54 | $0.21 | ||
| Q3 24 | $-1.34 | $0.15 | ||
| Q2 24 | $-1.67 | $0.09 | ||
| Q1 24 | $-1.44 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $183.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $497.5M |
| Total Assets | $689.8M | $751.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $183.9M | ||
| Q3 25 | $325.3M | $180.5M | ||
| Q2 25 | $303.0M | $203.1M | ||
| Q1 25 | $300.9M | $208.5M | ||
| Q4 24 | $315.4M | $181.5M | ||
| Q3 24 | $327.3M | $198.3M | ||
| Q2 24 | $315.7M | $225.4M | ||
| Q1 24 | $331.4M | $262.1M |
| Q4 25 | $88.3M | $497.5M | ||
| Q3 25 | $73.7M | $489.9M | ||
| Q2 25 | $73.1M | $493.2M | ||
| Q1 25 | $53.2M | $481.3M | ||
| Q4 24 | $57.0M | $491.3M | ||
| Q3 24 | $92.9M | $492.0M | ||
| Q2 24 | $102.9M | $489.6M | ||
| Q1 24 | $144.0M | $505.9M |
| Q4 25 | $689.8M | $751.9M | ||
| Q3 25 | $669.3M | $748.7M | ||
| Q2 25 | $639.8M | $747.2M | ||
| Q1 25 | $596.7M | $729.2M | ||
| Q4 24 | $568.5M | $747.2M | ||
| Q3 24 | $561.5M | $742.5M | ||
| Q2 24 | $548.2M | $736.0M | ||
| Q1 24 | $545.7M | $756.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $12.3M |
| Free Cash FlowOCF − Capex | $-18.7M | $11.6M |
| FCF MarginFCF / Revenue | -9.6% | 6.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $35.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $12.3M | ||
| Q3 25 | $1.0M | $-3.8M | ||
| Q2 25 | $-32.4M | $-7.2M | ||
| Q1 25 | $-43.4M | $39.1M | ||
| Q4 24 | $-26.2M | $-4.7M | ||
| Q3 24 | $-18.6M | $-17.8M | ||
| Q2 24 | $-30.1M | $-18.1M | ||
| Q1 24 | $-53.5M | $69.4M |
| Q4 25 | $-18.7M | $11.6M | ||
| Q3 25 | $988.0K | $-5.1M | ||
| Q2 25 | $-32.4M | $-8.7M | ||
| Q1 25 | $-43.7M | $37.5M | ||
| Q4 24 | $-26.2M | $-7.2M | ||
| Q3 24 | $-18.7M | $-20.1M | ||
| Q2 24 | $-30.2M | $-19.7M | ||
| Q1 24 | $-53.6M | $67.8M |
| Q4 25 | -9.6% | 6.2% | ||
| Q3 25 | 0.6% | -3.1% | ||
| Q2 25 | -21.6% | -6.6% | ||
| Q1 25 | -36.0% | 20.7% | ||
| Q4 24 | -22.1% | -4.0% | ||
| Q3 24 | -17.9% | -12.8% | ||
| Q2 24 | -34.6% | -14.7% | ||
| Q1 24 | -71.4% | 38.6% |
| Q4 25 | 0.0% | 0.4% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.3% | 0.9% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.1% | 1.5% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | — | 1.28× | ||
| Q3 25 | — | -1.27× | ||
| Q2 25 | — | -5.08× | ||
| Q1 25 | — | 4.86× | ||
| Q4 24 | — | -0.98× | ||
| Q3 24 | — | -5.14× | ||
| Q2 24 | — | -8.97× | ||
| Q1 24 | — | 7.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
MOV
| Other | $81.4M | 44% |
| Owned Brands Category | $46.0M | 25% |
| Sales Channel Directly To Consumer | $35.3M | 19% |
| Company Stores | $23.4M | 13% |
